Phase 2 roughly 30% cos
phase 3 goes to 60% but is also indication/disease state dependent
so if both trials are successful it adds serious value to the company on a risked dcf basis
Phase 2 roughly 30% cosphase 3 goes to 60% but is also...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $159.3M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $631.5K | 2.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8582 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 50910 | 6 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 29.5¢ | 27.5¢ | 1588896 | ||
| Last updated 15.57pm 19/04/2024 ? | |||||
| DXB (ASX) Chart |